logo

For the Inventor, By the Inventor

Uppsala, Sweden

Bo Nilsson

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 88(Granted Patents)


Location History:

  • Graso, 71 Oregrund, SE (1990)
  • 71 Oregrund, SE (1991)
  • 71 Oregrung, SE (2000)
  • Uppsala, SE (2006 - 2019)

Company Filing History:

goldMedal6 out of 15 
 
Tx Medic Ab
 patents
silverMedal1 out of 1 
 
Allvivo, Inc.
 patent
bronzeMedal1 out of 2 
 
Tikomed Ab
 patents
4. 1 out of 1,500 
 
Astrazeneca Ab
 patents
5. 1 out of 5 
 
Corline Systems Ab
 patents
6. 5 out of 832,891 
Other
 patents

Years Active: 1990-2019

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 10307440 - Use of dextran sulfate (2019-06-04),
2. 9446066 - Methods for reducing pulmonary uptake of intravenously injected cells (2016-09-20),
3. 9364499 - Use of dextran sulfate (2016-06-14),
4. 8906884 - Method of treating graft-rejection using dextran sulfate (2014-12-09),
5. 8901104 - Use of dextran sulfate (2014-12-02),
6. 8629123 - Use of dextran sulfate (2014-01-14),
7. 8048437 - Medical device with surface coating comprising bioactive compound (2011-11-01),
8. 7981873 - Use within transplantation surgery (2011-07-19),
9. 7955613 - Bioartificial implant and its use and method of reducing the risk for formation of connective tissue after implantation (2011-06-07),
10. 7858108 - Elutable surface coating (2010-12-28),
11. 7459169 - Surface coating comprising bioactive compound (2008-12-02),
12. 7045502 - Use of melagatran for the manufacture of a medicament for the treatment of Type 1 diabetes mellitus (2006-05-16),
13. 6137209 - High power ultrasonic transducer (2000-10-24),
14. 5075050 - Method for controlling some parameters in connection with manufacturing (1991-12-24),
15. 4944903 - Method for regulating the working and the output of plastic material in (1990-07-31),

Title: Bo Nilsson: Innovator in Therapeutic Cell Transplantation

Introduction

Bo Nilsson is a prominent inventor based in Uppsala, Sweden. He has made significant contributions to the field of therapeutic cell transplantation, holding a total of 15 patents. His innovative work focuses on improving the efficacy and safety of cell therapies for human patients.

Latest Patents

Among his latest patents is a composition that utilizes dextran sulfate in a graft intended for transplantation. This composition comprises an injection solution that includes an isolated therapeutic cell transplant, which is beneficial for human patients. The dextran sulfate used in this context has an average molecular weight of less than 20,000 Da. Another notable patent addresses methods for reducing pulmonary uptake of intravenously injected cells. In this patent, dextran sulfate is employed to minimize the pulmonary uptake of these cells, achieving levels comparable to intra-arterial injection without the associated risks and side effects. This innovation can be particularly useful in treating metastatic cancer by combining dextran sulfate with tumor-infiltrating T-lymphocytes.

Career Highlights

Bo Nilsson has worked with various companies throughout his career, including Tx Medic AB. His work has been instrumental in advancing therapeutic techniques and improving patient outcomes in the field of cell transplantation.

Collaborations

Throughout his career, Bo has collaborated with notable individuals such as Olle Korsgren and Jonas Andersson. These collaborations have contributed to the development of innovative solutions in therapeutic cell applications.

Conclusion

Bo Nilsson's contributions to the field of therapeutic cell transplantation highlight his role as a leading inventor. His patents and collaborations reflect a commitment to advancing medical science and improving treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…